Vascular Endothelial Growth Factor Receptor-2

Acronym

Definition

VEGFR-2

References in periodicals archive	?		Acronyms browser	?		Full browser	?
The studies provide additional evidence that CYC116 inhibits Aurora kinases and Vascular Endothelial Growth Factor Receptor-2 tyrosine kinase or VEGFR-2 kinase. Cyclacel Pharmaceuticals Presents Insights into the Mechanisms of Its ... by Business Wire NEW YORK -- ImClone Systems Incorporated (NASDAQ: IMCL) today announced the commencement of patient treatment in a Phase I clinical trial of its fully human monoclonal antibody targeting the vascular endothelial growth factor receptor-2 (VEGFR-2), IMC-1121B, in patients with solid tumors. ImClone Systems Commences Patient Treatment in U.S. Phase I Clinical ... by Business Wire IMC-1121B is a fully human monoclonal antibody that is designed to bind to the vascular endothelial growth factor receptor-2 (VEGFR-2 or KDR) found on tumor vasculature, thereby inhibiting certain ligands known as vascular endothelial growth factors from binding to and activating the receptor. ImClone Systems Receives U.S. Patent Covering Therapeutic ... by Business Wire	VAS-F VAS-H VAS-I VAS-P VAS-S VAS-X VAS/CCOPE VAS8 VASA VASAB VASAG VASAP VASARI VASAT VASB VASBO VASC VASCAN VASCAR VASCD VASCI VASCIC VASCM VASCO VASCON Vascular Endothelial Growth Factor Receptor-2 VASD VASDHS VASDIP VASDR VASE VASEA VASEP VASES VASF VASFAA VASG VASGBI VASH VASHPO VASI VASIE VASIMR VASIP/COSIG VASIS VASITE VASJ VASKhNIL VASL VASLA VASLE	Vascular disease Vascular disease Vascular disease Vascular Disease Foundation Vascular Disease of Plants Vascular Disease Program Vascular Disease Risk Factors vascular diseases vascular disorders of the proximal femur Vascular Ehlers-Danlos Syndrome vascular ejection sound vascular ejection sound vascular ejection sound vascular ejection sound Vascular Endothelial Cell Growth Factor Vascular Endothelial Cell Growth Factor-A Vascular endothelial growth factor Vascular endothelial growth factor Vascular endothelial growth factor Vascular endothelial growth factor Vascular endothelial growth factor Vascular endothelial growth factor Vascular Endothelial Growth Factor B Vascular Endothelial Growth Factor C vascular endothelial growth factor C/D receptor Vascular Endothelial Growth Factor D Vascular Endothelial Growth Factor Neutralizing Antibody Vascular endothelial growth factor receptor Vascular Endothelial Growth Factor Receptor 1 Vascular Endothelial Growth Factor Receptor 2 Vascular Endothelial Growth Factor Receptor-2 Vascular endothelial growth factors Vascular endothelial growth factors Vascular Endothelial Growth Inhibitor Vascular Endothelial Hyperplasia Vascular Endothelial Junction-Associated Molecule Vascular Endothelial Surface Index Vascular Endothelial Surface Score Vascular Endothelial Zinc Finger 1 vascular endothelium Vascular Endothelium Fibrinolytic Activity vascular engorgement vascular engorgement vascular engorgement Vascular Epidermal Growth Factor vascular fasciculus vascular goiter vascular goiter vascular goiter vascular graft vascular graft vascular graft vascular graft vascular graft vascular grafts vascular grafts vascular grafts vascular hamartoma vascular hamartoma vascular hamartoma Vascular headache

References in periodicals archive

Acronyms browser

Full browser

The studies provide additional evidence that CYC116 inhibits Aurora kinases and Vascular Endothelial Growth Factor Receptor-2 tyrosine kinase or VEGFR-2 kinase.

Cyclacel Pharmaceuticals Presents Insights into the Mechanisms of Its ... by Business Wire

NEW YORK -- ImClone Systems Incorporated (NASDAQ: IMCL) today announced the commencement of patient treatment in a Phase I clinical trial of its fully human monoclonal antibody targeting the vascular endothelial growth factor receptor-2 (VEGFR-2), IMC-1121B, in patients with solid tumors.

ImClone Systems Commences Patient Treatment in U.S. Phase I Clinical ... by Business Wire

IMC-1121B is a fully human monoclonal antibody that is designed to bind to the vascular endothelial growth factor receptor-2 (VEGFR-2 or KDR) found on tumor vasculature, thereby inhibiting certain ligands known as vascular endothelial growth factors from binding to and activating the receptor.

ImClone Systems Receives U.S. Patent Covering Therapeutic ... by Business Wire